innoscripta

Share & Analysts

Basic information

ISIN
DE000A40QVM8
Designation
New company (Open Market)
Segment at initial listing
Scale
Type of transaction
New issue
Instrument type (genus)
No-par-value bearer ordinary shares
Supersector
Information Technology
Sector
Software
Subsector
Software
Country
Germany
Stock exchange symbol
1INN
First day of trading
May 23, 2025
First price
€120.00
Emissions price
€120.00
Subscription period
16.05.2025-21.05.2025
Emission process
Book building process
Price range
€110.00-140.00
Consortium leader
Berenberg
Consortium
Sole Global Coordinator & Joint Bookrunner: Berenberg Joint Bookrunners: Hauck Aufhäuser, MMWarburg & CO
Placement volume excluding greenshoe
€189,600,000.00
Placement volume including greenshoe
€189,941,520.00
Placement volume of exercised greenshoe
€341,520.00
Capital increase in units
0
Reallocation in units
1,820,000
Available greenshoe (in pieces)
240,000
Greenshoe exercised in units
2,846
Preferred allocation
Shareholding friends & family
Share capital
10,000,000
Scattered ownership
15.82%
Remark
The offering shares comprise:
  • up to approximately 1.58 million existing shares in a base deal ("Secondary Base Shares");
  • up to approximately 0.28 million existing shares to cover the upsize option ("Secondary Upsize Shares"); and
  • up to approximately 0.28 million existing shares to cover the over-allotment option ("Over-Allotment Shares").

Ready to explore investment opportunities?

ir@innoscripta.com
+49 (0)89 255 553 509
Max Hunger

Max Hunger

Head of Investor Relations
innoscripta

The data layer for R&D, a continuous, verifiable record of the work your teams actually do, captured at source. Publicly listed, ISO 27001-certified, in 20+ countries.

innoscripta provides software solutions, documentation support, and general information on R&D funding. Our services do not include individual tax, legal, or financial advice.

Eligibility, funding rates, and potential outcomes depend on the applicable laws and regulations as well as the specific circumstances of the company and the respective project. Before submitting an application, we therefore recommend seeking qualified tax, legal, or financial advice where appropriate.

For further information, please refer to our information notice.



Copyright © 2026 - innoscripta SE

120 Wall Street, Fl 20, New York, USA

+1 315 758 3827

info@innoscripta.com

Share Basic Information | innoscripta Investor Relations